Targeting Hibernation Biology to Deliver Fat-Specific Weight Loss & Redefine Cardiometabolic Disease Management
12:00 pm - Thursday 10th December 2026
- Targeting Rexinoid Nuclear Receptor Signaling prevents adipose accumulation, improves insulin sensitivity, and drives selective fat loss without reducing food intake
- Demonstrates how adipose-focused therapies could address key limitations of GLP- 1s and offer a longer-term solution to restoring healthy metabolism
- Exploring the potential for durable improvements in obesity, type 2 diabetes, and liver health through enhanced basal metabolism
